Ufp Technologies (UFPT) Non-Current Deffered Revenue (2015 - 2026)
Ufp Technologies' (UFPT) quarterly Non-Current Deffered Revenue came in at $6.7 million in Q1 2026, up 4.69% YoY from $6.4 million in Q1 2025, and up 1.29% on a QoQ basis from $6.7 million in Q4 2025.
Ufp Technologies (UFPT) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 12 years of Non-Current Deffered Revenue data on file, last reported at $6.7 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 4.69% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 4.69% YoY) and the FY2025 annual result came in at $6.7 million, up 7.49% from the prior year.
- Non-Current Deffered Revenue rose to $6.7 million in Q1 2026, from $6.7 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $6.8 million in Q3 2025 to a low of $3.9 million in Q3 2022.
- A 5-year average of $5.5 million and a median of $5.7 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue dropped 4.12% — and 2023, when it climbed 29.88%.
- Tracing UFPT's Non-Current Deffered Revenue over 5 years: stood at $4.2 million in 2022, then increased by 29.88% to $5.4 million in 2023, then climbed by 14.43% to $6.2 million in 2024, then advanced by 7.49% to $6.7 million in 2025, then gained by 1.29% to $6.7 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $6.7 million (Q1 2026), $6.7 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Ufp Technologies | 2.34 Bn | 2.33 Bn | 50.92 Mn | 6.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.69 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 6.66 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.52 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 6.19 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 5.71 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 4.05 Mn |